A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA CoA Ratio via Dual Inhibition of PPAT and CPT1A. J. Can. Res. Updates 2025, 14, 247-265. https://doi.org/10.30683/1929-2279.2025.14.26.